相关实验视频
Updated: Jan 16, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
激活补充系统对抗脂综合征血栓瘤的影响:从病理生理学到治疗
Sofia Tagara1, Serena Valsami2, Eleni Gavriilaki3
1Laboratory of Hematology, General Hospital of Chania "St. George", 73100 Chania, Greece.
抗脂综合征 (APS) 涉及抗脂抗体 (aPL) 和第二个触发器,导致血栓形成. 补体系统越来越被认为是APS相关血栓形成的关键驱动因素,提供潜在的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 病理生理学 病理生理学
背景情况:
- 抗脂综合征 (APS) 是获得性血栓友的主要原因.
- 主流理论认为,这是一种"双重打击"模式,涉及抗脂抗体 (aPL) 和血栓形成的二次触发因素.
- 慢性免疫激活 aPL 破坏了免疫血栓的保护作用.
研究的目的:
- 审查补充系统调节失调在APS相关血栓形成中的作用.
- 在APS治疗的补充系统中识别潜在的治疗点.
主要方法:
- 对APS病理生理学中补充系统参与的当前研究进行审查.
- 分析aPL如何与补充元件相互作用.
- 评估补充系统作为治疗目标.
主要成果:
- 补体系统在驱动APS中的血栓形成中发挥着关键作用.
- aPL通过与血小板,β2-糖蛋白I和补充因子H的相互作用,促进补充系统过度激活.
- 补体系统的调节失调是APS病原体的核心.
结论:
- 补体系统是抗脂综合征中血栓形成的关键媒介.
- 针对补充系统为APS提供了一个有前途的治疗策略.
- 针对性治疗的进一步研究对于APS的精准医学至关重要.
更多相关视频
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Complement System
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...